Genetic variation in serotonin transporter function affects human fear expression indexed by fear-potentiated startle

Biological Psychology

Volumn 89, Issue 2, 2012, Pages 277-282

  Klumpers, Floris ^a   Heitland, Ivo ^a   Oosting, Ronald S ^a   Kenemans, J Leon ^a   Baas, Johanna M P ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

5 HTTLPR; Anxiety; COMT; DAT; Fear; HTR1A; Startle

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; ALLELE; ANXIETY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEAR; FEMALE; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STARTLE REFLEX; THREAT;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; ALLELES; ANXIETY; CUES; FEAR; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; REFLEX; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STARTLE REACTION;

EID: 84856335450     PISSN: 03010511     EISSN: 18736246     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2011.10.018     Document Type: Article

References (49)

1. Anders S., Lotze M., Erb M., Grodd W., Birbaumer N. Brain activity underlying emotional valence and arousal: a response-related fMRI study. Human Brain Mapping 2004, 23:200-209.
2. Armbruster D., Moser D.A., Strobel A., Hensch T., Kirschbaum C., Lesch K.P., Brocke B. Serotonin transporter gene variation and stressful life events impact processing of fear and anxiety. International Journal of Neuropsychopharmacology 2009, 12:393-401.
3. Baldwin D.S., Anderson I.M., Nutt D.J., Bandelow B., Bond A., Davidson J.R., den Boer J.A., Fineberg N.A., Knapp M., Scott J., Wittchen H.U. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 2005, 19:567-596.
4. Bandelow B., Zohar J., Hollander E., Kasper S., Moller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World Journal of Biological Psychiatry 2002, 3:171-199.
5. Blumenthal T.D., Cuthbert B.N., Filion D.L., Hackley S., Lipp O.V., van Boxtel A. Committee report: guidelines for human startle eyeblink electromyographic studies. Psychophysiology 2005, 42:1-15.
6. Bocker K.B., Baas J.M., Kenemans J.L., Verbaten M.N. Differences in startle modulation during instructed threat and selective attention. Biological Psychology 2004, 67:343-358.
7. Bradley M.M., Moulder B., Lang P.J. When good things go bad: the reflex physiology of defense. Psychological Sciences 2005, 16:468-473.
8. Brocke B., Armbruster D., Muller J., Hensch T., Jacob C.P., Lesch K.P., Kirschbaum C., Strobel A. Serotonin transporter gene variation impacts innate fear processing: acoustic startle response and emotional startle. Molecular Psychiatry 2006, 11:1106-1112.
9. Browning M., Reid C., Cowen P.J., Goodwin G.M., Harmer C.J. A single dose of citalopram increases fear recognition in healthy subjects. Journal of Psychopharmacology 2007, 21:684-690.
10. Canli T. Toward a neurogenetic theory of neuroticism. Annals of the New York Academy of Sciences 2008, 1129:153-174.
11. Caspi A., Hariri A.R., Holmes A., Uher R., Moffitt T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. American Journal of Psychiatry 2010, 167:509-527.
12. Cousijn H., Rijpkema M., Qin S., van Marle H.J., Franke B., Hermans E.J., van Wingen G., Fernandez G. Acute stress modulates genotype effects on amygdala processing in humans. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:9867-9872.
13. Crisan L.G., Pana S., Vulturar R., Heilman R.M., Szekely R., Druga B., Dragos N., Miu A.C. Genetic contributions of the serotonin transporter to social learning of fear and economic decision making. Social Cognition and Affective Neuroscience 2009, 4:399-408.
14. Dannlowski U., Konrad C., Kugel H., Zwitserlood P., Domschke K., Schoning S., Ohrmann P., Bauer J., Pyka M., Hohoff C., Zhang W., Baune B.T., Heindel W., Arolt V., Suslow T. Emotion specific modulation of automatic amygdala responses by 5-HTTLPR genotype. Neuroimage 2010, 53:893-898.
15. Davis M. Neural systems involved in fear and anxiety measured with fear-potentiated startle. American Psychologist 2006, 61:741-756.
16. Defares, P.B., Ploeg, H.M.v.d., Spielberger, C.D., 1980. Een nederlandstalige bewerking van de Spielberger State-Trait Anxiety Inventory: de Zelf-Beoordelings Vragenlijst.
17. Domschke K., Dannlowski U. Imaging genetics of anxiety disorders. Neuroimage 2010, 53:822-831.
18. Garpenstrand H., Annas P., Ekblom J., Oreland L., Fredrikson M. Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behavioral Neuroscience 2001, 115:358-364.
19. Grillon C., Ameli R., Merikangas K., Woods S.W., Davis M. Measuring the time course of anticipatory anxiety using the fear-potentiated startle reflex. Psychophysiology 1993, 30:340-346.
20. Grillon C., Ameli R., Woods S.W., Merikangas K., Davis M. Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex. Psychophysiology 1991, 28:588-595.
21. Grillon C., Baas J. A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clinical Neurophysiology 2003, 114:1557-1579.
22. Grillon C., Baas J.M. Comments on the use of the startle reflex in psychopharmacological challenges: impact of baseline startle on measurement of fear-potentiated startle. Psychopharmacology 2002, 164:236-238.
23. Grillon C., Levenson J., Pine D.S. A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology 2007, 32:225-231.
24. Hamm A.O., Vaitl D. Affective learning: awareness and aversion. Psychophysiology 1996, 33:698-710.
25. Hamm A.O., Weike A.I. The neuropsychology of fear learning and fear regulation. International Journal of Psychophysiology 2005, 57:5-14.
26. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
27. Hartley C.A., Phelps E.A. Changing fear: the neurocircuitry of emotion regulation. Neuropsychopharmacology 2010, 35:136-146.
28. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 1996, 66:2621-2624.
29. Heinz A., Braus D.F., Smolka M.N., Wrase J., Puls I., Hermann D., Klein S., Grusser S.M., Flor H., Schumann G., Mann K., Buchel C. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nature Neuroscience 2005, 8:20-21.
30. Karg K., Burmeister M., Shedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Archives of General Psychiatry 2011, 68:444-544.
31. Klumpers F., Raemaekers M.A., Ruigrok A.N., Hermans E.J., Kenemans J.L., Baas J.M. Prefrontal mechanisms of fear reduction after threat offset. Biological Psychiatry 2010, 68:1031-1038.
32. Klumpers F., van Gerven J.M., Prinssen E.P., Niklson I., Roesch F., Riedel W.J., Kenemans J.L., Baas J.M. Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans. Journal of Psychopharmacology 2010, 24:657-666.
33. Larson C.L., Ruffalo D., Nietert J.Y., Davidson R.J. Temporal stability of the emotion-modulated startle response. Psychophysiology 2000, 37:92-101.
34. Larson C.L., Taubitz L.E., Robinson J.S. MAOA T941G polymorphism and the time course of emotional recovery following unpleasant pictures. Psychophysiology 2010, 47:857-862.
35. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
36. Lissek S., Orme K., McDowell D.J., Johnson L.L., Luckenbaugh D.A., Baas J.M., Cornwell B.R., Grillon C. Emotion regulation and potentiated startle across affective picture and threat-of-shock paradigms. Biological Psychology 2007, 76:124-133.
37. Lonsdorf T.B., Ruck C., Bergstrom J., Andersson G., Ohman A., Schalling M., Lindefors N. The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:1479-1483.
38. Lonsdorf T.B., Weike A.I., Nikamo P., Schalling M., Hamm A.O., Ohman A. Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder. Psychological Sciences 2009, 20:198-206.
39. Munafo M.R., Brown S.M., Hariri A.R. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biological Psychiatry 2008, 63:852-857.
40. Munafo M.R., Freimer N.B., Ng W., Ophoff R., Veijola J., Miettunen J., Jarvelin M.R., Taanila A., Flint J. 5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data. American Journal of Medical Genetics B: Neuropsychiatric Genetics 2009, 150B:271-281.
41. Pacheco J., Beevers C.G., Benavides C., McGeary J., Stice E., Schnyer D.M. Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism. Journal of Neuroscience 2009, 29:6229-6233.
42. Pauli P., Conzelmann A., Mucha R.F., Weyers P., Baehne C.G., Fallgatter A.J., Jacob C.P., Lesch K.P. Affect-modulated startle reflex and dopamine D4 receptor gene variation. Psychophysiology 2010, 47:25-33.
43. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience 2005, 8:828-834.
44. Quirk G.J., Beer J.S. Prefrontal involvement in the regulation of emotion: convergence of rat and human studies. Current Opinion in Neurobiology 2006, 16:723-727.
45. Schardt D.M., Erk S., Nusser C., Nothen M.M., Cichon S., Rietschel M., Treutlein J., Goschke T., Walter H. Volition diminishes genetically mediated amygdala hyperreactivity. Neuroimage 2010, 53:943-951.
46. Schinka J.A., Busch R.M., Robichaux-Keene N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Molecular Psychiatry 2004, 9:197-202.
47. Sen S., Burmeister M., Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. American Journal of Medical Genetics B: Neuropsychiatric Genetics 2004, 127B:85-89.
48. Tottenham N., Tanaka J.W., Leon A.C., McCarry T., Nurse M., Hare T.A., Marcus D.J., Westerlund A., Casey B.J., Nelson C. The NimStim set of facial expressions: judgments from untrained research participants. Psychiatry Research 2009, 168:242-249.
49. Wankerl M., Wust S., Otte C. Current developments and controversies: does the serotonin transporter gene-linked polymorphic region (5-HTTLPR) modulate the association between stress and depression?. Current Opinion in Psychiatry 2010, 23:582-587.